Cargando…
Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
BACKGROUND: Intravenous immunoglobulin (IVIG) has been reported to exert a beneficial effect on severe fever with thrombocytopenia syndrome (SFTS) patients with neurological complications. However, in clinical practice, the standard regime is unclear and there is a lack of evidence from large-scale...
Autores principales: | Liu, Yun, Tong, Hanwen, He, Fei, Zhai, Yu, Wu, Chao, Wang, Jun, Jiang, Chenxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073413/ https://www.ncbi.nlm.nih.gov/pubmed/37033957 http://dx.doi.org/10.3389/fimmu.2023.1118039 |
Ejemplares similares
-
Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018) -
Immune escape mechanisms of severe fever with thrombocytopenia syndrome virus
por: Wang, Tong, et al.
Publicado: (2022) -
Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids
por: Ayesh, Hazem, et al.
Publicado: (2021) -
Immunoglobulin Therapy in a Patient With Severe Chikungunya Fever and Vesiculobullous Lesions
por: Fernandes, Ana Isabel V., et al.
Publicado: (2019) -
Early-Warning Immune Predictors for Invasive Pulmonary Aspergillosis in Severe Patients With Severe Fever With Thrombocytopenia Syndrome
por: Hu, Lifen, et al.
Publicado: (2021)